Dr Tom Newsom-Davis

Consultant Medical Oncologist


A specialist in "systemic anticancer treatments" for thoracic (lung cancers).

Dr Tom Newsom-Davis was appointed to Chelsea and Westminster Hospital in 2010, leading the lung cancer service. His work at Chelsea and Westminster has been awarded the national Macmillan Innovation Excellence Award and short-listed for the Health Services Journal Clinical Services award.

Tom leads the lung cancer group for the RM Partners Cancer Vanguard, which represents 3.5m patients in South and West London. At national level he is part of the steering group for the British Thoracic Oncology Group steering committee. In addition to his work in lung cancer, he also has an interest in acute oncology, leading the Chelsea & Westminster acute oncology unit and sitting on the National Acute Oncology expert reference group.

Dr Newsom-Davis is also very actively involved in teaching, being invited to lecture for various organisations including the Royal College of Physicians, International Association for the study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.

Dr Newsom-Davis is actively involved in lung cancer clinical trials, including being on the trial steering group and independent monitoring committees of a number of other studies. He is also a member of the National Cancer Research Institute (NCRI) lung cancer clinical study group.

Professional background


Dr Tom Newsom-Davis trained at University College and Middlesex School of Medicine, London, and graduated in anatomy and medicine in 1998. He specialised in medical oncology at Charing Cross and Hammersmith Hospitals, and during this time completed a PhD in tumour immunology, funded by Cancer Research UK. He went on to become a Clinical Lecturer in medical oncology at Imperial College London, supported by the Welcome Trust and Academy of Medical Sciences, before being appointed to Chelsea & Westminster as a consultant.

Services provided to HCA


Dr Newsom-Davis provides medical advisory services for HCA's Leaders in Oncology Care. In his role, Dr Newsom-Davis leads on Medical Governance for the hospital, reporting to the Medical Advisory Committee. He advises the hospital management team in key areas to develop clinical strategy in clinical governance, quality improvement and clinical performance.

He works with the Hospitalís CEO and Medical advisor in developing and putting in place effective systems and frameworks of clinical governance that are robust, workable, accepted by the majority of the body of clinicians at the Hospital and are in accordance with the statutory requirements and the relevant HCA policies.

Further to this, Dr Newsom-Davis leads on facilitating a bi-monthly morbidity and mortality (M&M) meeting to ensure detailed review and discussions take place for all deaths of patients being treated with systemic anticancer drugs. This ensures lessons are learned from adverse clinical outcomes, improvements are made service delivery, and supports services to achieve and maintain high standards of care.

Dr Newsom-Davis is also chair of The Harley Street Clinic Lung multi-disciplinary team meeting.

HCA UK is charged by doctors in return for their expertise and advice, including on how to operate safe hospital facilities delivering complex care.

All services provided under this agreement are charged to HCA UK.

HCA requires the doctors that advise us to attest that if they also practice in the NHS that they are not compromising their NHS commitments.

The information disclosed on this page in accordance with the Private Healthcare Market Investigation Order 2014 is true and accurate to the best of HCA’s knowledge and belief.